Use of sunitinib in patients with metastatic kidney cancer in real clinical practice
Over 200,000 new cases of renal-cell carcinoma (RCC) are notified worldwide every year. Examinations diagnose metastatic RCC (mRCC) in 25 % of primary patients; and after radical surgery 20–40 % of the patients are further diagnosed with disease progression and metastases. Randomized trials have dem...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
ABV-press
2016-05-01
|
| Series: | Onkourologiâ |
| Subjects: | |
| Online Access: | https://oncourology.abvpress.ru/oncur/article/view/549 |